Analysed ERASCA INC (ERAS:NASDAQ) News Sources
Erasca (ERAS) Is Down 13.4% After IP Challenge to ERAS-0015 Trade Secrets and Patents
08-06-2026
yahoo.com
Erasca (ERAS) Receives Encouraging Expert Feedback on ERAS-0015 Clinical Trials
11-06-2026
yahoo.com
VS-7375 Demonstrates Clinical Activity with a Favorable Safety and Tolerability Profile in TARGET-D 101 Phase 1/2 Clinical Trial in Patients with Advanced KRAS G12D-Mutated Solid Tumors
23-06-2026
yahoo.com
Verastem Says VS-7375 Trial Data Shows Anti-Tumor Activity in Advanced Solid Tumors
23-06-2026
yahoo.com
What is the current price of ERASCA INC (ERAS:NASDAQ)?
The current price of ERASCA INC (ERAS:NASDAQ) is $18.53.
ERASCA INC (ERAS:NASDAQ) absolute price change since previous trading day?
The absolute price change of ERASCA INC (ERAS:NASDAQ) since the previous trading day is $-0.65.
ERASCA INC (ERAS:NASDAQ) percentage price change since previous trading day?
The percentage price change of ERASCA INC (ERAS:NASDAQ) since the previous trading day is -3.3889%.
What is the most recent average sentiment score for ERASCA INC (ERAS:NASDAQ)?
The most recent average sentiment score for ERASCA INC (ERAS:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for ERASCA INC (ERAS:NASDAQ)?
The most recent sentiment for ERASCA INC (ERAS:NASDAQ) is .
SEC-8K** Filing Available For ERASCA INC (ERAS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.